← Back to search

Xvivo Perfusion AB

XVIPF · OTC MARKETS

Research and Development in Biotechnology

ESG Scores

Overall ESG

6.9

Environmental

6.6

Social

5.0

Governance

6.7

Gender Diversity

Female Directors0.5%

Women in Workforce0.5539999999999999%

CEO GenderMale